为促进中国骨关节炎外用药物有效、正确地选择运用，《中国骨关节炎外用药物临床实践指南》由中华医学会骨科学分会关节外科学组发起，同时成立指南相关工作组，严格遵循美国医学科学院(IOM)最新指南定义，依据世界卫生组织(WHO)标准版指南制定方法学，证据推荐分级(GRADE)、国际实践指南报告标准(RIGHT)以及证据质量评价工具(AGREE Ⅱ)完成指南计划书。

In order to promote the effective and correct selection and application of topical drugs for osteoarthritis in China, the Clinical Practice Guidelines for Topical Drugs for Osteoarthritis in China was initiated by the Joint Surgery Group of the Chinese Academy of Orthopedics, and a group of professionals working on the guidelines was set up in strict accordance with the definitions in latest guidelines of the Institution of Medicine (IOM) and to complete the prospectus of guidelines according to the guidelines for developing methodology issued by World Health Organization (WHO), Grade of Recommendations Assessment, Development and Evaluation (GRADE), Reporting Items for Practice Guidelines in Healthcare (RIGHT) and Appraisal of Guidelines Research and Evaluation II (AGREE II).